Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXTBiotechnology
+$0.46 today
- Market cap
- $89.11M
- Beta
- 1.05
- P/E (TTM)
- -11.1
- EPS (TTM)
- -$0.67
Volume 0.61M
Average 0.12M
Balance Sheet
Inspect the capital base behind the business.
Assets
$12.73M
FY 2025 · Annual
+1011.6% YoYLiabilities
$1.77M
FY 2025 · Annual
+456.8% YoYEquity
$10.96M
FY 2025 · Annual
+1225.1% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $3.3M |
| Other Current | $157.1K |
| Total Current Assets | $3.4M |
| PP&E (Net) | $850.1K |
| Other Non-current | $6.6M |
| Total Non-current Assets | $7.5M |
| Total Assets | $10.9M |
Analysis
Selected assets total $10.9M for Latest. The largest visible component is Other Non-current at $6.6M, about 60.8% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 3 | Initial statement of beneficial ownership | Jul 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 2, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jul 2, 2026 |
How much cash does LIXT have?
Lixte Biotechnology Holdings, Inc. (LIXT) reported $5.11M in cash and equivalents in fiscal 2025.
How much debt does LIXT carry?
Lixte Biotechnology Holdings, Inc. (LIXT) reported $664,491.00 of total debt, with net debt of -$4.44M.
Continue the stock analysis
Jump to another research area for this company.